🇺🇸 combined oral contraceptive in United States

37 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Rash — 5 reports (13.51%)
  2. Coma — 4 reports (10.81%)
  3. Headache — 4 reports (10.81%)
  4. Lupus-Like Syndrome — 4 reports (10.81%)
  5. Malaise — 4 reports (10.81%)
  6. Nausea — 4 reports (10.81%)
  7. Dizziness — 3 reports (8.11%)
  8. Drug Interaction — 3 reports (8.11%)
  9. Dyspepsia — 3 reports (8.11%)
  10. Loss Of Consciousness — 3 reports (8.11%)

Source database →

combined oral contraceptive in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is combined oral contraceptive approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for combined oral contraceptive in United States?

Jeffrey Jensen is the originator. The local marketing authorisation holder may differ — check the official source linked above.